318 related articles for article (PubMed ID: 22164265)
1. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway.
Finsen AV; Lunde IG; Sjaastad I; Østli EK; Lyngra M; Jarstadmarken HO; Hasic A; Nygård S; Wilcox-Adelman SA; Goetinck PF; Lyberg T; Skrbic B; Florholmen G; Tønnessen T; Louch WE; Djurovic S; Carlson CR; Christensen G
PLoS One; 2011; 6(12):e28302. PubMed ID: 22164265
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress.
Herum KM; Lunde IG; Skrbic B; Florholmen G; Behmen D; Sjaastad I; Carlson CR; Gomez MF; Christensen G
J Mol Cell Cardiol; 2013 Jan; 54():73-81. PubMed ID: 23178899
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
5. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
6. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
7. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
10. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
Herum KM; Lunde IG; Skrbic B; Louch WE; Hasic A; Boye S; Unger A; Brorson SH; Sjaastad I; Tønnessen T; Linke WA; Gomez MF; Christensen G
Cardiovasc Res; 2015 May; 106(2):217-26. PubMed ID: 25587045
[TBL] [Abstract][Full Text] [Related]
12. Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium.
Diedrichs H; Hagemeister J; Chi M; Boelck B; Müller-Ehmsen J; Schneider CA
J Int Med Res; 2007; 35(6):803-18. PubMed ID: 18034994
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
14. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
15. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
16. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
17. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
Liu Q; Chen Y; Auger-Messier M; Molkentin JD
Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241
[TBL] [Abstract][Full Text] [Related]
18. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P
J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448
[TBL] [Abstract][Full Text] [Related]
19. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
[TBL] [Abstract][Full Text] [Related]
20. FHL2 binds calcineurin and represses pathological cardiac growth.
Hojayev B; Rothermel BA; Gillette TG; Hill JA
Mol Cell Biol; 2012 Oct; 32(19):4025-34. PubMed ID: 22851699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
